An example advantage might be using the more low cost manufactured Manocept targeting molecule over say a vaccine. So, would not only be the most important advantage of Manocept of only targeting activated cell via internalization over the broader off targeting of non diseased as well as diseased cells by a vaccine, but the science/time/cost of extracting cells from the human body, culturing them, then re-injection as a vaccine, etc. is very high
From NWBO IV "Cells grow at the rate they decide
to grow, no faster and no slower, and there is precious little a
manufacturing process can do to change that. It is possible to automate
the manufacturing process which eliminates a lot of humans who are
involved in the process, potentially reducing the per unit cost
significantly, but it will never be an inexpensive because cell culture
is an inherently complex process. The required quality control tests
alone make it an expensive product.
Automation is cost justified when product
is produced at scale (i.e. several thousand units per year at each
manufacturing site)."
process
CC..Dr Rosol
The
fact that we can target macrophages of all type, the M1s, the M2s and
everything in between, with our construct means that we can deliver all
sorts of cool things, payloads, they're called loosely, to the
macrophage. And we can perturb them and drive them in different
directions. And we have a very flexible, adaptable molecule that has all
sorts of really great advantages over what almost every other group out
there is using. So I'm not just saying that because I work here. It's
proved.
